Global Health's Q1 FY 2025-26 Quarterly Results

Result Summary

• Global Health Ltd reported a 25.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 19.1%.
• Its expenses for the quarter were up by 26.6% QoQ and 16.7% YoY.
• The net profit increased 24.8% QoQ and increased 49.6% YoY.
• The earnings per share (EPS) of Global Health Ltd stood at 5.9 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Global Health Ltd is a company operating within the healthcare industry. Typically, companies in this sector focus on providing medical products, healthcare services, or pharmaceuticals. However, specific details regarding Global Health Ltd's main products or services, or any recent major developments, are not available from the provided data. A thorough understanding of the company's market position and product offerings requires additional information, which is not accessible in the current context.

Revenue

In Q1FY26, Global Health Ltd reported total income of ₹1,051.29 crores, marking a significant increase from ₹836.05 crores in Q4FY25 and ₹883.00 crores in Q1FY25. This translates to a quarter-over-quarter (QoQ) growth rate of 25.7% and a year-over-year (YoY) growth rate of 19.1%. The data indicates that the company has experienced substantial revenue growth both on a sequential and annual basis. The revenue figures suggest that the company has been successful in increasing its income over the past year, which might be a result of strategic initiatives or expanded market presence.

Profitability

Global Health Ltd's profitability has shown marked improvement as evidenced by several key metrics. The Profit Before Tax (PBT) for Q1FY26 stood at ₹208.14 crores, up from ₹143.09 crores in Q4FY25 and ₹143.65 crores in Q1FY25, representing a QoQ increase of 45.5% and a YoY increase of 44.9%. The Profit After Tax (PAT) was ₹158.98 crores in Q1FY26, compared to ₹127.35 crores in Q4FY25 and ₹106.27 crores in Q1FY25. This reflects a QoQ growth of 24.8% and a YoY growth of 49.6%. The company's earnings per share (EPS) also rose to ₹5.90 from ₹4.70 in the previous quarter and ₹4.00 in the same quarter last year, showing QoQ growth of 25.5% and YoY growth of 47.5%. These metrics highlight that the company has effectively managed to enhance its profitability over the periods considered.

Operating Metrics

Total expenses for Global Health Ltd in Q1FY26 were ₹862.74 crores, compared to ₹681.21 crores in Q4FY25 and ₹739.36 crores in Q1FY25. This corresponds to a QoQ increase of 26.6% and a YoY increase of 16.7%. The tax paid increased significantly to ₹49.16 crores from ₹15.74 crores in the previous quarter and ₹37.39 crores in the same quarter of the prior year, showing a QoQ increase of 212.3% and a YoY increase of 31.5%. The substantial increase in tax expenditure may be aligned with the company's improved profitability. The data indicates that while expenses have risen, the company's revenue and profitability have increased at a greater rate, potentially reflecting efficient operational management.